Skip to content
MedsAcross

Medicine

Metronidazole Vaginal Gel 0.75% vaginal gel

Metronidazole · Vaginal · Aurobindo Pharma
Available on requestPrescription onlyUS FDAIndian manufacturer

Metronidazole Vaginal Gel 0.75% vaginal gel is a prescription medicine containing Metronidazole for vaginal use, marketed by Aurobindo Pharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Protect from freezing. Store at 20° to 25°C (68° to 77°F), excursions…

Key facts

Active ingredient (INN)
Metronidazole
Brand
Metronidazole Vaginal Gel
Strength
0.75%
Dosage form
Vaginal gel
Route
Vaginal
Packs
1 tube
Marketing authorisation holder
Aurobindo Pharma
Manufacturer
Aurobindo PharmaIndia
Origin register
US FDA, United States
Storage
Protect from freezing. Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
A01AB17 Metronidazole
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
25 September 2026
Identifiers
RxCUI 142046DailyMed set ID 2ced2460-a003-4314-897b-f4ae0ff72edfNDC 59651-703Application ANDA218485

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
1 tube, with applicator in 1 carton / 70 g in 1 tube, with applicator59651-703-70Aurobindo PharmaIndia25 September 2026

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 18 July 1963Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Metronidazole 0.75% vaginal gel.

Compare all 6

Other strengths and forms of Metronidazole

Clinical summary

Metronidazole is a nitroimidazole antimicrobial indicated in the treatment of serious infections caused by susceptible anaerobic bacteria, among other approved uses. It is available as tablets, vaginal gel and gel for oral and topical use. MedsAcross supplies Metronidazole for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Metronidazole

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Metronidazole Vaginal Gel 0.75% vaginal gel for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.